Ketamine cousin tested for gut relief in IBS patients
NCT ID NCT06788444
Summary
This study is testing whether a single, low dose of the medication esketamine can help reduce symptoms and improve quality of life for people with irritable bowel syndrome (IBS). Researchers will give the drug to about 550 adults with IBS who are scheduled for a colonoscopy and also have anxiety or depression. They will measure changes in gut symptoms, mood, and overall well-being six weeks later.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IRRITABLE BOWEL SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing Tiantan Hospital
RECRUITINGBeijing, Beijing Municipality, 100050, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.